Rockefeller Capital Management L.P. Cytokinetics Inc Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$38.54 - $54.52 $3,776 - $5,342	-98 Reduced 75.97%	31 $1,000
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $3,969 - $5,723	117 Added 975.0%	129 $5,000
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $356 - $552	12 New	12 $0
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $1,854 - $3,574	-100 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$19.79 - $26.99 $11,874 - $16,193	-600 Reduced 85.71%	100 $1,000
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $4,578 - $8,583	300 Added 75.0%	700 $14,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $8,232 - $11,584	400 New	400 $8,000

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.